Trupanion, Inc. (NASDAQ:TRUP) Receives $41.83 Consensus Target Price from Analysts

Shares of Trupanion, Inc. (NASDAQ:TRUPGet Free Report) have received a consensus rating of “Moderate Buy” from the seven ratings firms that are presently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among brokers that have covered the stock in the last year is $41.83.

A number of equities research analysts have recently weighed in on the company. Bank of America raised their price target on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Evercore ISI upgraded shares of Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Piper Sandler increased their price target on shares of Trupanion from $38.00 to $45.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 2nd. Stifel Nicolaus lifted their price objective on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 23rd. Finally, William Blair assumed coverage on Trupanion in a research note on Friday, July 19th. They set an “outperform” rating for the company.

Get Our Latest Report on TRUP

Insider Activity

In related news, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the sale, the chief executive officer now directly owns 99,984 shares of the company’s stock, valued at $4,647,256.32. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Fawwad Qureshi sold 624 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $46.54, for a total transaction of $29,040.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the sale, the chief executive officer now directly owns 99,984 shares in the company, valued at approximately $4,647,256.32. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 8,764 shares of company stock valued at $405,238. Insiders own 5.50% of the company’s stock.

Institutional Investors Weigh In On Trupanion

Several large investors have recently modified their holdings of TRUP. 8 Knots Management LLC boosted its stake in Trupanion by 87.0% in the first quarter. 8 Knots Management LLC now owns 1,297,485 shares of the financial services provider’s stock worth $35,824,000 after purchasing an additional 603,775 shares in the last quarter. Renaissance Technologies LLC acquired a new position in Trupanion during the 2nd quarter worth about $4,739,000. Hosking Partners LLP bought a new stake in Trupanion during the 2nd quarter worth about $3,523,000. Marshall Wace LLP increased its position in Trupanion by 11.9% in the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock valued at $32,181,000 after acquiring an additional 116,496 shares in the last quarter. Finally, GSA Capital Partners LLP increased its position in Trupanion by 376.5% in the 1st quarter. GSA Capital Partners LLP now owns 80,046 shares of the financial services provider’s stock valued at $2,210,000 after acquiring an additional 63,247 shares in the last quarter.

Trupanion Stock Up 1.0 %

Shares of Trupanion stock opened at $53.61 on Friday. Trupanion has a 1 year low of $19.14 and a 1 year high of $55.74. The company has a market cap of $2.25 billion, a P/E ratio of -83.77 and a beta of 1.73. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. The stock has a 50-day moving average price of $46.12 and a 200 day moving average price of $35.24.

Trupanion (NASDAQ:TRUPGet Free Report) last posted its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.04. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. The business had revenue of $314.80 million during the quarter, compared to analyst estimates of $309.33 million. During the same period in the prior year, the firm earned ($0.33) earnings per share. The firm’s revenue was up 16.3% compared to the same quarter last year. As a group, analysts expect that Trupanion will post -0.34 EPS for the current fiscal year.

Trupanion Company Profile

(Get Free Report

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Stories

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.